Skip to main content

Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Synergism between Prior Anisakis simplex Infections and Intake of NSAIDs, on the Risk of Upper Digestive Bleeding: A Case-Control Study.

PMID: 21738810
Journal: PLoS Neglected Tropical Diseases
Year: 2011
Reference: PLoS Negl Trop Dis. 2011 Jun;5(6):e1214. Epub 2011 Jun 28.
Impact factor: 4.752
Publication type: Paper in international publication
Authors: Lopez-Goikoetxea, Maria Jose, Ibanez, Luisa, Figueiras, Adolfo, Aguirre, Carmelo, Ortega, Sara, Salgado, Angel, Ubeira, Florencio M, Anadon, Ana M, Carvajal, Alfonso et al.
DOI: 10.1371/journal.pntd.0001214

Synergism between Prior Anisakis simplex Infections and Intake of NSAIDs, on the Risk of Upper Digestive Bleeding: A Case-Control Study.

PMID: 21738810
Journal: PLoS Neglected Tropical Diseases
Year: 2011
Reference: PLoS Negl Trop Dis. 2011 Jun;5(6):e1214. Epub 2011 Jun 28.
Impact factor:
Publication type: Paper in international publication
Authors: Aguirre, Carmelo; Anadon, Ana M; Carvajal, Alfonso; Figueiras, Adolfo; Ibanez, Luisa; Lopez-Goikoetxea, Maria Jose; Ortega, Sara; Salgado, Angel; Ubeira, Florencio M et al.
DOI: 10.1371/journal.pntd.0001214

Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism.

PMID: 21600050
Journal: BREAST CANCER RESEARCH
Year: 2011
Reference: Breast Cancer Res. 2011 May 22;13(3):R54.
Impact factor: 5.785
Publication type: Paper in international publication
Authors: , , , et al.
DOI: 10.1186/bcr2888

Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism.

PMID: 21600050
Journal: BREAST CANCER RESEARCH
Year: 2011
Reference: Breast Cancer Res. 2011 May 22;13(3):R54.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; et al.
DOI: 10.1186/bcr2888

Synovial fibroblast hyperplasia in rheumatoid arthritis: Clinicopathological correlations and partial reversal by anti-tumor necrosis factor therapy.

PMID: 21547893
Journal: ARTHRITIS AND RHEUMATISM
Year: 2011
Reference: Arthritis Rheum. 2011 Sep;63(9):2575-83. doi: 10.1002/art.30433.
Impact factor: 8.435
Publication type: Paper in international publication
Authors: , , , , , , , , et al.
DOI: 10.1002/art.30433

Synovial fibroblast hyperplasia in rheumatoid arthritis: Clinicopathological correlations and partial reversal by anti-tumor necrosis factor therapy.

PMID: 21547893
Journal: ARTHRITIS AND RHEUMATISM
Year: 2011
Reference: Arthritis Rheum. 2011 Sep;63(9):2575-83. doi: 10.1002/art.30433.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; ; et al.
DOI: 10.1002/art.30433

Systematic reviews and meta-analysis: scientific rationale and interpretation.

PMID: 21719182
Journal: REVISTA ESPANOLA DE CARDIOLOGIA
Year: 2011
Reference: Rev Esp Cardiol. 2011 Aug;64(8):688-96. Epub 2011 Jun 30.
Impact factor: 2.157
Publication type: Review in national publication
Authors: Ferreira Gonzalez, Ignacio, Urrutia, Gerard, Alonso-Coello, Pablo et al.
DOI: 10.1016/j.recesp.2011.03.029

Systematic reviews and meta-analysis: scientific rationale and interpretation.

PMID: 21719182
Journal: REVISTA ESPANOLA DE CARDIOLOGIA
Year: 2011
Reference: Rev Esp Cardiol. 2011 Aug;64(8):688-96. Epub 2011 Jun 30.
Impact factor:
Publication type: Review in national publication
Authors: Alonso-Coello, Pablo; Ferreira Gonzalez, Ignacio; Urrutia, Gerard et al.
DOI: 10.1016/j.recesp.2011.03.029

Systemic lupus erythematosus as a first presentation of common variable immunodeficiency associated with infrequent mannose-binding lectin gene polymorphisms.

PMID: 19851769
Journal: RHEUMATOLOGY INTERNATIONAL
Year: 2011
Reference: Rheumatol Int. 2011 Apr;31(4):537-41. Epub 2009 Oct 23.
Impact factor: 1.431
Publication type: Paper in international publication
Authors: , , , , et al.
DOI: 10.1007/s00296-009-1209-8

Systemic lupus erythematosus as a first presentation of common variable immunodeficiency associated with infrequent mannose-binding lectin gene polymorphisms.

PMID: 19851769
Journal: RHEUMATOLOGY INTERNATIONAL
Year: 2011
Reference: Rheumatol Int. 2011 Apr;31(4):537-41. Epub 2009 Oct 23.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; et al.
DOI: 10.1007/s00296-009-1209-8

T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.

PMID: 20627965
Journal: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Year: 2011
Reference: J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):72-7. Epub 2010 Jul 13.
Impact factor: 4.791
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1136/jnnp.2009.201574

T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.

PMID: 20627965
Journal: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Year: 2011
Reference: J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):72-7. Epub 2010 Jul 13.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1136/jnnp.2009.201574

Targeted impairment of thymidine kinase 2 expression in cells induces mitochondrial DNA depletion and reveals molecular mechanisms of compensation of mitochondrial respiratory activity.

PMID: 21382338
Journal: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Year: 2011
Reference: Biochem Biophys Res Commun. 2011 Apr 8;407(2):333-8. Epub 2011 Mar 5.
Impact factor: 2.595
Publication type: Paper in international publication
Authors: , , , , , , , et al.
DOI: 10.1016/j.bbrc.2011.03.018

Targeted impairment of thymidine kinase 2 expression in cells induces mitochondrial DNA depletion and reveals molecular mechanisms of compensation of mitochondrial respiratory activity.

PMID: 21382338
Journal: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Year: 2011
Reference: Biochem Biophys Res Commun. 2011 Apr 8;407(2):333-8. Epub 2011 Mar 5.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; et al.
DOI: 10.1016/j.bbrc.2011.03.018

Targeted therapies development in the treatment of advanced nonsmall cell lung cancer.

PMID: 22219656
Journal: JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
Year: 2011
Reference: J Biomed Biotechnol. 2011;2011:415641. Epub 2011 Dec 18.
Impact factor: 1.225
Publication type: Editorail in international publication
Authors: Gridelli, Cesare, Felip, Enriqueta et al.
DOI: 10.1155/2011/415641

Targeted therapies development in the treatment of advanced nonsmall cell lung cancer.

PMID: 22219656
Journal: JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
Year: 2011
Reference: J Biomed Biotechnol. 2011;2011:415641. Epub 2011 Dec 18.
Impact factor:
Publication type: Editorail in international publication
Authors: Felip, Enriqueta; Gridelli, Cesare et al.
DOI: 10.1155/2011/415641

Telaprevir for retreatment of HCV infection.

PMID: 21696308
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2011
Reference: N Engl J Med. 2011 Jun 23;364(25):2417-28.
Impact factor: 53.484
Publication type: Paper in international publication
Authors: Picchio, Gaston, Pol, Stanislas, Lawitz, Eric, Diago, Moises, Roberts, Stuart, Focaccia, Roberto, Younossi, Zobair, Foster, Graham R, Horban, Andrzej, Ferenci, Peter et al.
DOI: 10.1056/NEJMoa1013086

Telaprevir for retreatment of HCV infection.

PMID: 21696308
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2011
Reference: N Engl J Med. 2011 Jun 23;364(25):2417-28.
Impact factor:
Publication type: Paper in international publication
Authors: Afdhal, Nezam; Agarwal, Kaushik; Andreone, Pietro; Andreone, Pietro; Arora, Sanjeev; Ascione, Antonio; Baruch, Yaacov; Benari, Ziv; Benhamou, Yves; Berg, Thomas et al.
DOI: 10.1056/NEJMoa1013086

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease.

PMID: 21254162
Journal: HEPATOLOGY
Year: 2011
Reference: Hepatology. 2011 Jan;53(1):62-72. doi: 10.1002/hep.23952. Epub 2010 Oct 27.
Impact factor: 10.885
Publication type: Paper in international publication
Authors: Liaw, Yun-Fan, Sheen, I-Shyan, Lee, Chuan-Mo, Akarca, Ulus Salih, Papatheodoridis, George V, Suet-Hing Wong, Florence, Chang, Ting-Tsung, Horban, Andrzej, Wang, Chia, Kwan, Peter et al.
DOI: 10.1002/hep.23952

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease.

PMID: 21254162
Journal: HEPATOLOGY
Year: 2011
Reference: Hepatology. 2011 Jan;53(1):62-72. doi: 10.1002/hep.23952. Epub 2010 Oct 27.
Impact factor:
Publication type: Paper in international publication
Authors: Akarca, Ulus Salih; Berg, Thomas; Buti, Maria; Chang, Ting-Tsung; Frederick, David; Horban, Andrzej; Kitrinos, Kathryn; Kwan, Peter; Lee, Chuan-Mo; Liaw, Yun-Fan et al.
DOI: 10.1002/hep.23952

THC and CBD oromucosal spray (Sativex((R))) in the management of spasticity associated with multiple sclerosis.

PMID: 21456949
Journal: Expert review of neurotherapeutics
Year: 2011
Reference: Expert Rev Neurother. 2011 May;11(5):627-37. Epub 2011 Apr 1.
Impact factor:
Publication type: Letter or abstract
Authors: , , , et al.
DOI: 10.1586/ern.11.47

THC and CBD oromucosal spray (Sativex((R))) in the management of spasticity associated with multiple sclerosis.

PMID: 21456949
Journal: Expert review of neurotherapeutics
Year: 2011
Reference: Expert Rev Neurother. 2011 May;11(5):627-37. Epub 2011 Apr 1.
Impact factor:
Publication type: Letter or abstract
Authors: ; ; ; et al.
DOI: 10.1586/ern.11.47

The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy.

PMID: 21811581
Journal: PLoS One
Year: 2011
Reference: PLoS One. 2011;6(7):e22284. Epub 2011 Jul 21.
Impact factor: 4.411
Publication type: Paper in international publication
Authors: Annibali, Daniela, Carucci, Nicoletta, Favuzzi, Emilia, Cole, Michael D, Evan, Gerard I, Soucek, Laura, Nasi, Sergio, Savino, Mauro et al.
DOI: 10.1371/journal.pone.0022284

The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy.

PMID: 21811581
Journal: PLoS One
Year: 2011
Reference: PLoS One. 2011;6(7):e22284. Epub 2011 Jul 21.
Impact factor:
Publication type: Paper in international publication
Authors: Annibali, Daniela; Carucci, Nicoletta; Cole, Michael D; Evan, Gerard I; Favuzzi, Emilia; Nasi, Sergio; Savino, Mauro; Soucek, Laura et al.
DOI: 10.1371/journal.pone.0022284